Natixis’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,703
Closed -$15.4K 1047
2023
Q1
$15.4K Sell
2,703
-168
-6% -$958 ﹤0.01% 865
2022
Q4
$29K Buy
+2,871
New +$29K ﹤0.01% 900
2021
Q3
Sell
-2,891
Closed -$251K 1225
2021
Q2
$251K Buy
+2,891
New +$251K ﹤0.01% 798